Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-01-24 @ 5:59 PM
Study NCT ID:
NCT00059904
Status:
COMPLETED
Last Update Posted:
2013-07-18
First Post:
2003-05-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-01
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-06
Completion Date Type:
ACTUAL
First Submit Date:
2003-05-06
First Submit QC Date:
None
Study First Post Date:
2003-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-17
Last Update Post Date:
2013-07-18
Last Update Post Date Type:
ESTIMATED